Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.
At least four killed in Israeli strike on building in Lebanon's Baalbek
Qatar busts two cells linked to Iran’s Revolutionary Guard
GCC condemns Iranian attack on Port of Fujairah
Jordanian airspace reopens after 'comprehensive review'
Iran vows to attack any ship trying to pass through Strait of Hormuz
